ASML

In the end, you can only hope that you don't regret it. European shares in the summer sale.

Today I bought the last tranche of Carl Zeiss Meditec $AFX (-3,63 %) today. The reason is of course that I am still convinced of the company, but nobody can say how long it will be before the share comes back to life.

It could probably go down even further, but I have decided not to buy any more from now on as the position is large enough and otherwise my risk management will no longer work.

Overall, I have increased my position size from around 1% to just over 3%, which already represents a clear commitment to a German company, which is known to be particularly volatile.

The same applies to L'Oreal $OR (+0,93 %) here, too, I have finished buying with a buy-in of €365 and have reached a position size that is already approaching the 4% portfolio weighting. The shares will probably continue to fall for the time being, which I will simply have to hold on to.

I would now rather concentrate on other opportunities such as Thermo Fisher $TMO (+0,94 %) where I have already doubled down this month. Here, however, I can well imagine buying significantly more if prices fall.

It cannot be ruled out that, if the market as a whole weakens, LVMH $MC (-1,51 %) and $ASML (+2,43 %) a first purchase could take place. With the four stocks already mentioned here (+ $NOVO B (-2,31 %) ) mentioned here, I believe that the potential of Western European equities has already been fully exhausted.

It's just a difficult case. Europe is currently more attractive than ever before compared to the hot American market. Either you can seize the opportunity of the decade NOW and bet on a recovery of the European economy, then the champagne corks will pop here in two years' time. Or there will be a complete implosion of the European economy (and then the double-digit losses in the portfolio will be the least of our problems)

Reallocation in the portfolio:

Out went $AFX (-3,63 %)

New in $ASML (+2,43 %)

The decision was not easy, as I am still convinced of Meditec, but unfortunately the market simply sees things differently at the moment.

I see more upside for ASML as a shovel seller and more downside for Meditec with the possible tariff war between USA - Europe - China ( Asia accounts for a third of sales in 2023 according to Trading View )

Meditec remains on the watch while I wait for the quarterly figures on 11.12

$ASML (+2,43 %) - get in now or wait?🤔

What do you think? When is the best time to $ASML (+2,43 %)
to get in?

How do you rate the long-term potential of this tech giant in the semiconductor market?

Also: What are your predictions for the share's performance up to 2025?📈

I'm looking forward to your opinions 👇

#ASML
#Investieren
#Halbleiter
#Aktien-analysis #Prognose2025

I set up a custody account with Scalable Capital last week.

In addition to my cash flow depotwhich currently pays me a dividend of €709.45 next year (see picture), I will set up a savings plan custody account there.

This savings plan custody account will have a term of 20 years+.

I will pay in €495 per month and divide it between 15 companies as follows:

$GOOGL (-4,72 %) - 33€

$AMZN (-1,53 %) - 33€

$AAPL (+0,85 %) -33€

$ASML (+2,43 %) - 33€

$FAST (+1,15 %) - 33€

$JNJ (+2,61 %) - 33€

$MC (-1,51 %) - 33€

$MCD (-0,6 %) - 33€

$MSFT (+0,01 %) - 33€

$NOVO B (-2,31 %) - 33€

$PEP (+0,95 %) - 33€

$PG (+1,67 %) - 33€

$UNP (+2,4 %) - 33€

$UNH (+0,14 %) - 33€

$V (+1,35 %) - 33€

The savings plans will be executed for the first time on Monday and then continue on a monthly basis.

I will post a monthly update here

Pair of chips taken from the table.

Then slowly moves into candidates like $ASML (+2,43 %) , $MC (-1,51 %) , $NOVO B (-2,31 %)

Profit taking:

Reallocation of 40% into $VWCE (+1,06 %) , 10% $IGLN (+1,31 %) and 50% in individual stocks $8035 (-0,34 %) , $GOOG (-4,63 %) , $ASML (+2,43 %) , $MSFT (+0,01 %)